Who
Matthew Ferguson
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Elutia; Chief Financial Officer, Avinger; Chief Financial Officer, Foxhollow Technologies.
In numbers
- Trades disclosed
- 156
- Buys
- 9
- Sells
- 20
- Bought
- $232K
- Sold
- $2.4M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 9 Jan 2006
- Last trade
- 10 Sep 2026
- Last filed
- 14 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 14 Sep 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —12,500 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $3,5894,486 at $0.80 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —12,500 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $3,5894,486 at $0.80 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —12,500 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $4,6644,485 at $1.04 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —12,500 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $4,6644,485 at $1.04 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —12,500 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $5,5845,123 at $1.09 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —12,500 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $5,5845,123 at $1.09 | filing |
| 1 Jan 2026filed 5 Jan 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —368,000 at $0.00 | filing |
| 1 Jan 2026filed 5 Jan 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —368,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.